These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36322622)

  • 1. Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysis.
    Virmani I; Oteo A; Dunn M; Vidler D; Roper C; Officer J; Hardy G; Dargan PI; Eddleston M; Cooper JG; Hill SL; Macfarlane R; Keating L; Haden M; Hudson S; Thomas SHL
    Clin Toxicol (Phila); 2023 Jan; 61(1):39-46. PubMed ID: 36322622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?
    Tebo C; Mazer-Amirshahi M; DeGeorge L; Gelfand B; Leak C; Tolliver S; Sauter D
    Am J Emerg Med; 2019 Oct; 37(10):1846-1849. PubMed ID: 30595429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features associated with ADB-BUTINACA exposure in patients attending emergency departments in England.
    King A; Hill SL; Pucci M; Bailey G; Keating L; Macfarlane R; Cantle F; Hudson S; Thomas SHL
    Clin Toxicol (Phila); 2022 Oct; 60(10):1094-1098. PubMed ID: 35943421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201.
    McQuade D; Hudson S; Dargan PI; Wood DM
    Eur J Clin Pharmacol; 2013 Mar; 69(3):373-6. PubMed ID: 22936123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015.
    Abouchedid R; Hudson S; Thurtle N; Yamamoto T; Ho JH; Bailey G; Wood M; Sadones N; Stove CP; Dines A; Archer JRH; Wood DM; Dargan PI
    Clin Toxicol (Phila); 2017 Jun; 55(5):338-345. PubMed ID: 28421836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: a report from the United Kingdom National Poisons Information Service.
    Waugh J; Najafi J; Hawkins L; Hill SL; Eddleston M; Vale JA; Thompson JP; Thomas SH
    Clin Toxicol (Phila); 2016 Jul; 54(6):512-8. PubMed ID: 27091041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytically confirmed illicit and novel psychoactive drug use in Western Australian emergency departments: initial results from the Emerging Drugs Network of Australia (EDNA).
    Weber C; Smith JL; Soderstrom J; Burrows S; McCutcheon D; Oosthuizen F; Fatovich DM;
    Clin Toxicol (Phila); 2023 Jul; 61(7):500-508. PubMed ID: 37449677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs in blood and urine samples from victims of suspected exposure to drink spiking: A prospective observational study from Oslo, Norway.
    Dalaker VM; Furuhaugen H; Brekke M; Bjørnaas MA; Krpo M; Øiestad EL; Vallersnes OM
    PLoS One; 2024; 19(7):e0306191. PubMed ID: 38985694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project.
    Lin CC; Weng TI; Ng CJ; Shih CP; Hsu J; Liao YC; Yang CC; Fang CC;
    Clin Toxicol (Phila); 2022 Jun; 60(6):708-715. PubMed ID: 35315299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of analytically confirmed illicit substance-using patients in the Emergency Department.
    Weng TI; Chen LY; Chen JY; Chen PS; Hwa HL; Fang CC
    J Formos Med Assoc; 2020 Dec; 119(12):1827-1834. PubMed ID: 32037264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentations to an urban emergency department in Bern, Switzerland associated with acute recreational drug toxicity.
    Liakoni E; Müller S; Stoller A; Ricklin M; Liechti ME; Exadaktylos AK
    Scand J Trauma Resusc Emerg Med; 2017 Mar; 25(1):26. PubMed ID: 28264690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intoxications involving MDPV in Sweden during 2010-2014: Results from the STRIDA project.
    Beck O; Franzen L; Bäckberg M; Signell P; Helander A
    Clin Toxicol (Phila); 2015 Nov; 53(9):865-73. PubMed ID: 26462932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act.
    Craft S; Dunn M; Vidler D; Officer J; Blagbrough IS; Pudney CR; Henderson G; Abouzeid A; Dargan PI; Eddleston M; Cooper J; Hill SL; Roper C; Freeman TP; Thomas SHL
    Addiction; 2022 Nov; 117(11):2899-2906. PubMed ID: 35665553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute health problems due to recreational drug use in patients presenting to an urban emergency department in Switzerland.
    Liakoni E; Dolder PC; Rentsch K; Liechti ME
    Swiss Med Wkly; 2015; 145():w14166. PubMed ID: 26218967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SODAS: Surveillance of Drugs of Abuse Study.
    Lowe DJ; Torrance HJ; Ireland AJ; Bloeck F; Stevenson R
    Eur J Emerg Med; 2017 Apr; 24(2):126-129. PubMed ID: 26313317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.
    Hill SL; Najafi J; Dunn M; Acheampong P; Kamour A; Grundlingh J; Blain PG; Thomas SH
    Clin Toxicol (Phila); 2016 Sep; 54(8):638-43. PubMed ID: 27251903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic cannabinoid use among a sample of individuals enrolled in community-based recovery programs: Are synthetic cannabinoids actually preferred to other drugs?
    Smith KE; Staton M
    Subst Abus; 2019; 40(2):160-169. PubMed ID: 30457960
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute recreational drug toxicity: Comparison of self-reports and results of immunoassay and additional analytical methods in a multicenter European case series.
    Liakoni E; Yates C; Dines AM; Dargan PI; Heyerdahl F; Hovda KE; Wood DM; Eyer F; Liechti ME;
    Medicine (Baltimore); 2018 Feb; 97(5):e9784. PubMed ID: 29384873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project.
    Bäckberg M; Lindeman E; Beck O; Helander A
    Clin Toxicol (Phila); 2015 Jan; 53(1):46-53. PubMed ID: 25422862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICA.
    Seywright A; Torrance HJ; Wylie FM; McKeown DA; Lowe DJ; Stevenson R
    Clin Toxicol (Phila); 2016 Sep; 54(8):632-7. PubMed ID: 27213960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.